Status: Recruiting
Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN
The clinical trial is planned as a prospective, multicentre, blinded, randomised, placebo-controlled, national clinical trial in Germany. The clinical trial is designed for testing the prophylactic and therapeutic effects of Aconite pain oil as compared to placebo in oncological patients receiving neurotoxic chemotherapy with taxanes and/or platinum derivatives.
Participants needed: 350
Trial details
Phase: Phase 3Age: 18-100Biological sex: AllType: InterventionalSponsor: WALA Heilmittel GmbHUpdated: Sep 2, 2025Locations: 1
Eligibility criteria
A consent form, fully dated and signed by the patient and the principal investig... [+6]
Participation in an interventional trial (with an investigational product) that... [+21]